| Items | Drug Registration information |
|---|---|
| ID | 884 |
| No | 884 |
| Brand Name | CABOMAKS 20 |
| Ingredients | CABOZANTINIB 20 MG |
| Dosage Form | CAPSULE |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 3 YEARS |
| Pack Size | BOX OF 30'S/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR THE TREATMENT OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) WHO HAVE BEEN PREVIOUSLY TREATED WITH SORAFENIB |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | WHITE CAPSULE CONTAINS WHITE TO YELLOW GRANULES |
| Note | |
| License Owner | FACTORY NO.2 |
| Manufacturer | FACTORY NO. 2 |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 11 L 1235/24 |
| FDD Registration Date | 13/11/2024 |
| Expiry Date | 12/11/2029 |